Loring Wolcott & Coolidge Fiduciary Advisors’s LumiraDx Limited Common Shares LMDX Stock Holding History
Bought
Maintained
Sold
Other funds holding LMDX
Loring Wolcott & Coolidge Fiduciary Advisors's LMDX Position: Q1 2024 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of LumiraDx Limited Common Shares (LMDX) in Q1 2024, closing a stake of 12,820 shares — an estimated $196 sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in LMDX in Q3 2022 and held it in 6 quarters. The position peaked at $13K in Q3 2022. 4 funds tracked by Wall St. Rank hold LMDX as of Q1 2024.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining LumiraDx Limited Common Shares position as of Q1 2024 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 12,820 LumiraDx Limited Common Shares shares in Q1 2024, an estimated $196.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in LumiraDx Limited Common Shares in Q3 2022 and held it in 6 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's LumiraDx Limited Common Shares position peaked at $13K in Q3 2022.
- 4 funds tracked by Wall St. Rank held LumiraDx Limited Common Shares as of Q1 2024.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.